Over a billion people suffer from diseases that impact the back of their eyes. Advanced opthalmic imaging open new avenues to better diagnose and treat these pathologies.
Imagine Eyes’ solutions enable examining patients’ retinas with an unprecedented level of detail – the cellular level – thanks to adaptive optics technology.
AO imaging lets you see what conventional retinal imaging cannot: damage at the level of individual cells, vascular wall remodeling, and other subclinical microlesions – directly in patients’ retinas.
For clinical research and retinal therapy development, this means new discoveries in disease mechanisms, and highly sensitive cellular biomarkers to de-risk and accelerate development programs.
Publications in the spotlight
Latest news
https://www.imagine-eyes.com/wp-content/uploads/AOvision2026-banner-website.png
508
1400
contrib
https://www.imagine-eyes.com/wp-content/uploads/logo.svg
contrib2026-02-20 15:44:042026-05-29 16:35:28AO-VISION Symposium
https://www.imagine-eyes.com/wp-content/uploads/banner-for-event-webinar2-v2.png
500
1691
contrib
https://www.imagine-eyes.com/wp-content/uploads/logo.svg
contrib2025-11-25 17:44:532025-11-26 20:08:02Retinal Microvasculature as a Window into Systemic Health
Non-neovascular AMD: update on candidate AO biomarkers
Regenerative retinal therapy evaluated with adaptive optics imaging
Early atrophic changes in AMD captured by rtx1
Cone cells before/after macular hole surgery
Photoreceptor changes in diabetes: new findings published